SLC5A2 and diabetes mellitus: However, the guidelines give strong recommendation to use select GDMT agents for compelling indications such as hypertension with ACEi/ARB, diabetes or CVD with SGLT-2 inhibitors, and recent myocardial infarction with EF ≤40% with beta blockers [4].